MYC proteins also drive epigenetic activation of gene expression in prostate cancer; the PRC2 member EZH2 is directly upregulated by MYC [137] and MYCN, which was shown to be a driver of NEPC [66] by inducing an EZH2-mediated transcriptional program [64]. This evidence concerns the gene EZH2 and prostate cancer.